Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 3

eBook: US $99 Special Offer (PDF + Printed Copy): US $206
Printed Copy: US $157
Library License: US $396
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-1-68108-290-5 (Print)
ISBN: 978-1-68108-289-9 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810828991160301

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect.

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Ana M. Urbano
Unidade de Química-Física Molecular and Departamento de Ciências da Vida
Faculdade de Ciências e Tecnologia, Universidade de Coimbra
Coimbra
Portugal


Ascensión López Díaz de Cerio
Hematology Department
Clínica Universidad de Navarra
Pamplona
Spain


Carlos Panizo
Hematology Department
Clínica Universidad de Navarra
Pamplona
Spain


Chi Chun Wong
Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease
Li Ka Shing Institute of Health Sciences, Shenzhen Research Institute, The Chinese University of Hong Kong
Hong Kong


C. Karthikeyan
Departamento de Química e Bioquímica
Faculdade de Ciências, Universidade do Porto, s/n, Rua do Campo Alegre
4169-007 Porto
Portugal


David M. Straughan
Department of Surgery
University of South Florida, Morsani College of Medicine
Tampa, FL
USA


Esther Pena
Hematology Department
Complejo Hospitalario de Navarra
Pamplona
Spain


Jun Yu
Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease
Li Ka Shing Institute of Health Sciences, Shenzhen Research Institute, The Chinese University of Hong Kong
Hong Kong


N.S. Hari Narayana Moorthy
Departamento de Química e Bioquímica
Faculdade de Ciências, Universidade do Porto
s/n, Rua do Campo Alegre, 4169-007
India
/
School of Pharmaceutical Sciences
Rajiv Gandhi Proudyogiki Vishwavidyalaya
Airport Bypass Road, Gandhi Nagar, Bhopal (MP)-462033
Porto
Portugal


Nicolás Martínez-Calle
Hematology Department
Clínica Universidad de Navarra
Pamplona
Spain


Patrícia L. Abreu
Unidade de Química-Física Molecular and Departamento de Ciências da Vida
Faculdade de Ciências e Tecnologia, Universidade de Coimbra
Coimbra
Portugal


Piyush Trivedi
School of Pharmaceutical Sciences
Rajiv Gandhi Proudyogiki Vishwavidyalaya
Bhopal (MP)-462033
Airport Bypass Road, Gandhi Nagar
India


Ricardo García-Muñoz
Hematology Department
Hospital San Pedro
Logroño
Spain


Robert D. Bennett
Department of Surgery
University of South Florida, Morsani College of Medicine
Tampa, FL
USA


Rodney B. Luwor
Department of Surgery
The Royal Melbourne Hospital, The University of Melbourne
Parkville, Victoria 3050
Australia


Saïd C. Azoury
Department of Surgery
The Johns Hopkins Hospital
Baltimore, MD
USA


Susana Inogés
Hematology Department
Clínica Universidad de Navarra
Pamplona
Spain


Vivek Shukla
Thoracic and GI Oncology Branch
National Cancer Institute, National Institutes of Health
Bethesda, MD
USA




RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.